Tag: Europe
-
Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial
Global drug makers Sanofi and GlaxoSmithKline are starting a clinical trial testing a vaccine to prevent Covid-19 infections among healthy adults in the U.S.
-
Food Allergy Biotech Acquired for $2.6B
Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion.
-
Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy
Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells.
-
Sanofi Acquires Immune Disease Biotech in $3.7B Deal
A developer of small-molecule therapies for autoimmune diseases, including multiple sclerosis, and other immune disorders is being acquired by Sanofi.
-
Trial Testing Rare Disease Drug for Covid-19 Pneumonia
A clinical trial is underway assessing a drug approved for a rare inherited disease as a treatment for people hospitalized with pneumonia from Covid-19 infections.
-
Infographic – Mental Health Effects of Pandemic
Physical symptoms experienced by people with Covid-19 infections are well documented over the past few months, but the psychological toll is also beginning to get attention.
-
Synthetic Protein Maker Raises $91.3M in Venture Funds
A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round.
-
Pharma Companies Form $1B Antibiotics Fund
A group of 23 pharmaceutical companies are creating an investment fund to finance research and development of new drugs to combat antibiotic resistance.
-
EC, France Fund Universal Covid-19, Flu Vaccines
A biotechnology company is receiving European Commission and French government funds to develop vaccines that protect against all strains of Covid-19 and flu viruses.
-
Mobile App Screens for Sleep Apnea
A medical software team designed a mobile app that records and analyzes a person’s sounds and sleep positions to detect signs of sleep apnea.